Blog | HemaCare

Plasmonic Nano Vectors Can Activate Dendritic Cells

Aug 25, 2017 12:23:31 PM / by Stacy Matthews Branch, DVM, PhD posted in cancer treatment, Dendritic cells, Nanotechnology, pnv

0 Comments

Conventional cancer treatment strategies are toxic to normal cells and lead to severe adverse effects for patients with cancer. To avoid exposure of chemotherapeutic agents to healthy tissue, controlled delivery of drugs targeting only tumor tissue would have significant clinical value. Research efforts in developing nanotechnology-based delivery systems can provide significant cancer treatment options; however, the choice of materials is crucial for their efficacy and safety.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts